Extendicare Inc. ("Extendicare" or the "Company") announced today that its wholly owned home health care subsidiary, ParaMed Inc. ("ParaMed" or the "Purchaser"), has entered into an agreement to ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, ...

Please provide your email address to receive an email when new articles are posted on . Electronic provider notification led to more aortic valve replacement procedures after a diagnosis of severe ...

Aortic stenosis is the most common valvular lesion in patients above the age of 65. The etiology, presentation, and management of aortic stenosis differs in the elderly compared to younger ...

In the case of this question, the aortic valve. A patient can be born with stenosis of the aortic valve (AS). One can also develop it because of rheumatic heart disease resulting from a strep ...

It’s no surprise that complications can vex concomitant procedures. But when staged, should PCI or TAVI come first?

Normal E/A ratio of about 1:2 in an elderly patient with aortic stenosis and left ventricular hypertrophy is indicative of pseudo-normalization (see Figure 7). PW=pulsed wave; MV DT=mitral valve ...

currently valued at over $6 billion (around ₹51,600 crore), and witnessing strong growth driven by the increasing incidence of aortic stenosis and rising demand for minimally invasive cardiac ...